Endotoxicity of bacterial vaccines was quantitated in mice by using actinomycin D as potentiating agent. The results were compared with those obtained by the mouse weight gain test. The lethality of Escherichia coli lipopolysaccharide was increased 2,140 times when 12.5 ,ug of actinomycin D was used. The mean lethal dose values of heated and unheated pertussis vaccines were similar in the actinomycin D enhancement assay, but the unheated vaccine was significantly more toxic in the mouse weight gain test. Acetone-inactivated typhoid vaccine was slightly less toxic than the heatphenol-inactivated vaccine in both the actinomycin D enhancement assay and mouse weight gain test. Endotoxicity of experimental vaccines prepared by extraction of Pseudomonas aeruginosa strains was high as compared with E. coli lipopolysaccharide. The BALB/c mice were about four times more susceptible than the random bred NIH strain mice. The results indicate that the actinomycin D enhancement assay had the advantages of being more sensitive and probably more specific.
Endotoxicity of bacterial vaccines was quantitated in mice by using actinomycin D as potentiating agent. The results were compared with those obtained by the mouse weight gain test. The lethality of Escherichia coli lipopolysaccharide was increased 2,140 times when 12.5 ,ug of actinomycin D was used. The mean lethal dose values of heated and unheated pertussis vaccines were similar in the actinomycin D enhancement assay, but the unheated vaccine was significantly more toxic in the mouse weight gain test. Acetone-inactivated typhoid vaccine was slightly less toxic than the heatphenol-inactivated vaccine in both the actinomycin D enhancement assay and mouse weight gain test. Endotoxicity of experimental vaccines prepared by extraction of Pseudomonas aeruginosa strains was high as compared with E. coli lipopolysaccharide. The BALB/c mice were about four times more susceptible than the random bred NIH strain mice. The results indicate that the actinomycin D enhancement assay had the advantages of being more sensitive and probably more specific.
Several antimetabolites have been found to be capable of enhancing the toxic effect of bacterial endotoxin in experimental animals. Mitomycin C increased this endotoxicity in mice by a factor of five (5) . Sparsomycin and pactamycin were found to enhance the ability of endotoxin to cause hemorrhage and death (10) . Actinomycin D potentiated the toxicity of pertussis vaccine (6) and significantly increased the lethality of endotoxin in mice (1, 3, 4) . Recently, a method was described for quantitation of endotoxin in mice by using actinomycin D as a potentiating agent (11) . In view of its simplicity and sensitivity, we have studied the feasibility of this method for quantitation of endotoxicity in bacterial vaccines. The mouse weight gain (MWG) test was done simultaneously as a reference (12 housed in plastic isolators and monitored as previously described (14) .
Chemicals. Escherichia coli 026:B6 lipopolysaccharide (control 547237) and Salmonella typhosa 0901 lipopolysaccharide (control 542510) were purchased from Difco Laboratories, Detroit, Mich. Actinomycin D (Lyovac Cosmegen) lots 2429N and 2304M were from Merck, Sharp & Dohme, West Point, Pa. Methotrexate (Lederle Laboratories, Pearl River, N.Y.), cyclophosphamide (Mead Johnson Laboratories, Evansville, Ind.), 5-fluorouracil (Roche Laboratories, Nutley, N.J.), mitomycin C (Bristol Laboratories, Syracuse, N.Y.), 6-mercaptopurine (Burroughs Wellcome Co., Research Triangle Park, N.C.) were obtained from Cancer Chemotherapy, National Service Center, NIH.
Vaccines. The U.S. Standard Typhoid Vaccine lot 6A, acetone-inactivated and dried, and typhoid vaccine L, heat-phenol-killed and dried, were prepared from Salmonella typhosa strain Ty 2 and standardized by bacterial counts (7, 17) . Acetone-inactivated and dried typhoid vaccines, designated by us as lots 1, 2, 3, and 4 were prepared by Wyeth Laboratories, Inc., Marietta, Pa.
Pertussis vaccine lot 1 and lot 2 were derived from one batch of inactivated bacterial concentrate. One portion was freeze-dried as lot 1. Another portion was heated at 56 C for 10 min to inactivate primarily the dermonecrotic toxin, and then freeze-dried as lot 2. They were standardized in terms of U.S. opacity units and are used experimentally by the Bureau of 403 Biologics, Food and Drug Administration, for vaccine toxicity studies.
Pseudomonas vaccine lots A and B were extracts of Pseudomonas aeruginosa strains. Similar extracts have been used as experimental vaccine for clinical studies.
Actinomycin D enhancement assay. Groups of 10 mature mice (22 to 26 g each) were injected intraperitoneally with 1 ml of saline solution containing actinomycin D and serial fivefold dilutions of a bacterial vaccine or lipopolysaccharide. Inoculum for the negative control group consisted of actinomycin D only in 1 ml of saline per mouse. Survival was observed for 3 days. Mean lethal dose (LD,0) values were calculated by the logit method (2). Weighted
LD5. values and weighted relative toxicity were calculated by the method of Finney (9) . Mouse weight gain test. Male mice of the NIH strain, weighing individually 14 to 16 g, were randomized into groups of 10 and given free access to food and water for at least 2 h before injection and throughout the experiment. Each group was injected intraperitoneally with 1 ml of a test dose of vaccine or lipopolysaccharide per animal. The control animals were given 1 ml of saline each. Three or more fivefold dilutions of a vaccine or lipopolysaccharide weie used. The group weight of the mice was determined immediately prior to injection and at the end of 1, 2, 3, and 7 days after injection (12) .
RESULTS AND DISCUSSION
Potentiating effect of actinomycin D. Enhancement of lethality of endotoxin in mice by actinomycin D was dose dependent (Table  1) . Practically no potentiating effect was observed when 3.1 gg of actinomycin D per mouse was used. As the dosage of actinomycin D was increased to 12.5 sg and 20 ug per animal, respectively, the LD50 values of E. coli lipopolysaccharide were reduced from 500.9 ,gg to 0.23 Ag and 0.013 ug. This represents a 2,140and 39,290-fold increase in lethality of the lipopolysaccharide. However, 23% of the control mice died 3 days after injection of 20 ,g of actinomycin D. potentiating factor of about 125,000 in the LD,0 2 days after injection. Dowling and Feldman (8) reported that 25 ug of actinomycin D was lethal in a significant proportion of mice up to 7 days. Our observations are in general agreement with their findings. Adult mice of the NIH and BALB/c strains tolerated well 12.5 Mg of actinomycin D, and no severe overt side effects or death occurred during the 3-day period in the control groups which had received only actinomycin D. A 2,140-fold increase in lethality due to E. coli lipopolysaccharide was obtained at this dose level.
Influence of mice. The results of relation between body weight (age) and susceptibility of mice to toxicity of actinomycin D are given in Table 2 . Since mice weighing less than 18 g each succumbed more readily to the lethal effect of actinomycin D, adult mice weighing 22 to 26 g individually were used for quantitative studies.
The difference in susceptibility to the lethal effect of endotoxin in the presence of actinomycin D was studied in two strains of mice, i.e., NIH and BALB/c ( Table 3 ). The BALB/c strain was about four times more susceptible than the NIH strain. This higher sensitivity of BALB/c mice does not seem to be causedonly by the possible difference in intestinal flora between these two strains of mice (15), as a difference in susceptibility of practically the same magnitude was also observed in gnotobiotic mice of the same strains. Gnotobiotic mice were about 40 times more resistant to the lethal effect of endotoxin than their conventional counterparts. The conventional NIH strain was used for the rest of our experiments. Both NIH and BALB/c mice tolerated well the dose of actinomycin D employed in this experiment, but its relative enhancing effect on endotoxin lethality for the two strains was not evaluated.
Determination of endotoxicity of bacterial vaccines. Pertussis vaccine lot 1 and lot 2 were compared by the actinomycin D enhancement assay (ADE) ( Table 4 ) and the MWG test (Fig. 1) . The weighted LD50 of lot 1 (0.104 opacity unit) is not significantly different from that of lot 2 (0.121 opacity unit) as determined by the ADE assay. Lot 1, however, was significantly more toxic than lot 2 in the MWG test. Intraperitoneal inoculation of 20 opacity units of lot 1 vaccine killed 90% of the test animals, wLereas all the mice given the same dose of lot 2 vaccine survived. Previous work in this laboratory showed that the LD50 value for lot 1 was 16 opacity units in comparison with 58 opacity Weighted LD50 0.104 ± 0.020 0.121 ± 0.029 a Lot 1 was unheated and lot 2 was heated at 56 C for 10 min to inactivate primarily the dermonecrotic toxin. Adult NIH male mice were injected intraperitoneally with 12.5 jig of actinomycin D, lot 2304 M, mixed with various amounts of vaccine in 1 ml of saline. Survival was recorded for 3 days. Relative toxicity of lot 1 to lot 2, 0.859. 90% Confidence limits of relative toxicity, (0.497, 1.485). units for lot 2 (C. R. Manclark, personal communication).
Since lot 2 had been "detoxified" by heating at 56 C for 10 min for the purpose of inactivating primarily the heat-labile dermonecrotic and lethal toxin produced by B. pertussis, it appears that the ADE assay reflected more specifically the endotoxin content of the vaccines than the MWG test which measured "total" toxicity. It is unclear whether this apparent specificity of the ADE assay is due to its heightened sensitivity to endotoxin. An inoculum of about 10 opacity units was necessary for a reliable response in the MWG test, but a 100% death was obtained in the ADE assay with a dose of 1 opacity unit. It is probable that in the ADE assay the heat-labile toxins in lot 1 vaccine were diluted to an extent that they no longer contributed to the observed lethality. It should also be mentioned that Pieroni et al. (11) tested the effect of actinomycin D on tetanus and diphtheria toxins in CFW mice and found no potentiation.
Endotoxicity of two kinds of typhoid vaccine was studied (Table 5 ). By the ADE assay, a weighted LD50 of 3.27 x 10' cells was obtained for the acetone-inactivated U.S. Standard Typhoid Vaccine 6A as compared with 1.6 x 10' cells for vaccine L. This difference in endotoxicity, also reflected by the MWG test (Fig. 2) , was statistically significant. Spaun, Davidson, and Larsen (16) reported that the acetone-inactivated vaccine K was less toxic than vaccine L in a test based on weight changes in intraperitoneally vaccinated mice. The endotoxicity values of other acetone-inactivated typhoid vaccines also appeared to be consistently lower than vaccine L, but these differences were not significant.
Experimental of these patients was investigated. The antimetabolites were tested at a range of doses which exceeded the recommended doses for human adults on a body weight basis. Results are given in Table 6 . At the highest doses of antimetabolites tested, in a mixture with 20 Mg of lipopolysaccharide from S. typhosa strain 0901, no lethality was observed. The same lipopolysaccharide given together with 12 respectively. These values were consistent with the results of the MWG test (Fig. 3) .
Effect of other antimetabolites on lethality of endotoxin in mice. Vaccines prepared from gram-negative bacteria are becoming increasingly important in prophylaxis of bacterial infections in cancer or organ transplant patients. The ability to potentiate the lethality of endotoxicity in mice of other antimetabolites which are often used for treatment antimetabolites do not drastically increase the lethality associated with endotoxin administration. However, only a single dose of lipopolysaccharide (20 Mg) in combination with the various antimetabolites was tested, and at higher doses of endotoxin or antimetabolites some potentiation may be observed (5) . For measuring endotoxicity, the ADE assay has some advantages over the MWG test. The ADE assay is more sensitive and probably more specific for endotoxicity. It gives a direct comparison with the reference preparation in LD,0 values. Although the conditions of husbandry after inoculation are of paramount importance in the MWG test, they have little effect on the ADE assay as most of the animals die within 2 to 3 days. Like other biological assay systems, the ADE assay is subject to variations due to animals, reagents, and techniques.
The in vitro limulus lysate test (13) may offer an alternative for quantitation of solubilized endotoxin in bacterial extracts, but its usefulness in measuring endotoxin in total in cellular bacterial vaccines remains to be defined. 
